| Q33844763 | A potential role for creatine in drug abuse? |
| Q88615295 | Advances in cellular and integrative control of oxygen homeostasis within the central nervous system |
| Q35289471 | Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation |
| Q89178770 | Antenatal prevention of cerebral palsy and childhood disability: is the impossible possible? |
| Q36933096 | Cardiorespiratory coupling in health and disease |
| Q37480270 | Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. |
| Q43649228 | Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons |
| Q95819987 | Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease |
| Q51483904 | Creatine and creatine pyruvate reduce hypoxia-induced effects on phrenic nerve activity in the juvenile mouse respiratory system. |
| Q38742697 | Creatine for women: a review of the relationship between creatine and the reproductive cycle and female-specific benefits of creatine therapy. |
| Q48400901 | Creatine increases survival and suppresses seizures in the hypoxic immature rat. |
| Q28069271 | Creatine kinase in ischemic and inflammatory disorders |
| Q44430651 | Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate. |
| Q44714602 | Creatine protects the immature brain from hypoxic-ischemic injury. |
| Q48354579 | Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation. |
| Q46851841 | Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system |
| Q44787570 | Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury |
| Q42939723 | Early postnatal exposure to intermittent hypoxia in rodents is proinflammatory, impairs white matter integrity, and alters brain metabolism |
| Q44537154 | Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices |
| Q34666769 | Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? |
| Q89771004 | Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health |
| Q73172039 | Increase of cerebral phosphocreatine in normal rats after intracerebroventricular administration of creatine |
| Q48114355 | Increase of total creatine in human brain after oral supplementation of creatine-monohydrate |
| Q44438162 | Kinetics of creatine in blood and brain after intraperitoneal injection in the rat. |
| Q37976705 | Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and L-carnitine |
| Q30810394 | Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate |
| Q38706110 | Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease |
| Q58829455 | Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β-Amyloid in Rat Hippocampal Neurons |
| Q46946975 | Protective effects of some creatine derivatives in brain tissue anoxia |
| Q48114119 | Proton MRS of oral creatine supplementation in rats. Cerebral metabolite concentrations and ischemic challenge |
| Q46453510 | Supra- and sub-baseline phosphocreatine recovery in developing brain after transient hypoxia-ischaemia: relation to baseline energetics, insult severity and outcome |